PubRank

P H Barrett

Author PubWeight™ 57.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999 3.13
2 What's in a name? Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis. Am J Med 2000 2.09
3 Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 1996 1.59
4 Impact of reducing antibiotic prescribing for acute bronchitis on patient satisfaction. Eff Clin Pract 2001 1.55
5 The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest 2000 1.46
6 The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections. J Gen Intern Med 1999 1.35
7 Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 1999 1.35
8 Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J Lipid Res 2000 1.24
9 Factors associated with antibiotic use for acute bronchitis. J Gen Intern Med 1998 1.22
10 Public beliefs and use of antibiotics for acute respiratory illness. J Gen Intern Med 1999 1.20
11 Laparoscopic nephrectomy for renal cell cancer: evaluation of efficacy and safety: a multicenter experience. Urology 1998 1.09
12 Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler Thromb Vasc Biol 1999 1.06
13 Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 1993 1.03
14 The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab 2001 1.02
15 Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. Br J Clin Pharmacol 2000 1.01
16 Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am J Physiol Endocrinol Metab 2001 0.96
17 Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J Biol Chem 1999 0.95
18 Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE. Arterioscler Thromb Vasc Biol 2001 0.95
19 Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. J Clin Endocrinol Metab 1999 0.93
20 Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies. Metabolism 2000 0.92
21 Metastatic renal cell cancer after laparoscopic radical nephrectomy: long-term follow-up. J Endourol 2000 0.92
22 Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes. J Lipid Res 1996 0.91
23 ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. J Lipid Res 1992 0.89
24 Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler Thromb Vasc Biol 1995 0.87
25 Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arterioscler Thromb Vasc Biol 1997 0.86
26 Evaluation of an intervention to change benzodiazepine-prescribing behavior in a prepaid group practice setting. Am J Prev Med 1994 0.86
27 ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. Arterioscler Thromb Vasc Biol 1999 0.85
28 Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates. J Lipid Res 1999 0.84
29 Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Arterioscler Thromb Vasc Biol 1997 0.84
30 Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential. Nephrol Dial Transplant 2001 0.84
31 Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. J Lipid Res 1999 0.83
32 Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo. J Clin Invest 1992 0.83
33 Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. J Lipid Res 1999 0.83
34 Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler Thromb 1994 0.82
35 Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects. J Clin Endocrinol Metab 2000 0.82
36 Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. J Lipid Res 1997 0.81
37 Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Arterioscler Thromb Vasc Biol 2000 0.81
38 The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Arterioscler Thromb Vasc Biol 1998 0.80
39 The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs. Endocrinology 1999 0.80
40 Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women. J Lipid Res 2000 0.79
41 Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria. Clin Sci (Lond) 2000 0.79
42 Clearance of postprandial and lipolytically modified human HDL in rabbits and rats. J Lipid Res 1997 0.79
43 Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model. J Lipid Res 1998 0.79
44 Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia. Clin Investig 1993 0.78
45 Approaches to population kinetic analysis with application to metabolic studies. Adv Exp Med Biol 1998 0.78
46 Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J Lipid Res 1999 0.78
47 Effect of estrogen and progesterone on metabolism of apoprotein B in baboons. Am J Physiol 1990 0.77
48 Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp). Metabolism 1991 0.77
49 Dietary fish oil plus lovastatin decreases both VLDL and LDL apo B production in miniature pigs. Arterioscler Thromb 1992 0.77
50 Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test. Atherosclerosis 2001 0.77
51 Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia. Eur J Clin Invest 2001 0.77
52 Physiologic mechanisms of action of lovastatin in nephrotic syndrome. J Lipid Res 1995 0.77
53 Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test. J Lipid Res 2001 0.77
54 Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets. Metabolism 1995 0.76
55 Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys. J Lipid Res 2001 0.76
56 Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity. Clin Sci (Lond) 2001 0.76
57 Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia. J Lipid Res 1996 0.76
58 Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits. J Lipid Res 2001 0.76
59 Postmenopausal estrogen and the metabolism of plasma lipoproteins. N Engl J Med 1992 0.75
60 The elderly and poor in the medical outcomes study. JAMA 1996 0.75
61 HDL kinetics, fish oils and diabetes. Atherosclerosis 2001 0.75
62 A letter from Alexander Humboldt to Charles Darwin. J Hist Med Allied Sci 1972 0.75
63 A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males. Proc Soc Exp Biol Med 1999 0.75
64 Emergency excretory urography in blunt abdominal trauma. Can Assoc Radiol J 1991 0.75
65 Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B. J Lipid Res 2000 0.75
66 Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol. Biochim Biophys Acta 1998 0.75
67 High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy. Nutr Metab Cardiovasc Dis 2002 0.75
68 Assessment of prostatism. Can Fam Physician 1978 0.75
69 Low density lipoprotein apolipoprotein B metabolism: comparison of two methods to establish kinetic parameters. Atherosclerosis 1999 0.75